ASH 2020: Results of a trial investigating brentuximab vedotin for front line treatment of older patients with Hodgkin lymphoma.
Home / Resource Library / Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients